Vapotherm (VAPO) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

VAPO Stock Forecast


Vapotherm stock forecast is as follows: an average price target of $128.00 (represents a 5825.93% upside from VAPO’s last price of $2.16) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.

VAPO Price Target


The average price target for Vapotherm (VAPO) is $128.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $128.00 to $128.00. This represents a potential 5825.93% upside from VAPO's last price of $2.16.

VAPO Analyst Ratings


Hold

According to 2 Wall Street analysts, Vapotherm's rating consensus is 'Hold'. The analyst rating breakdown for VAPO stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (50.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).

Vapotherm Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 03, 2022Jason BednarPiper Sandler$128.00$105.6021.21%5825.93%
Row per page
Go to

The latest Vapotherm stock forecast, released on Oct 03, 2022 by Jason Bednar from Piper Sandler, set a price target of $128.00, which represents a 21.21% increase from the stock price at the time of the forecast ($105.60), and a 5825.93% increase from VAPO last price ($2.16).

Vapotherm Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.16$2.16$2.16
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Vapotherm stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Vapotherm's last price of $2.16. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 03, 2022Piper SandlerUnderweightUnderweightHold
Apr 26, 2022Zacks Investment Research-HoldUpgrade
Row per page
Go to

Vapotherm's last stock rating was published by Piper Sandler on Oct 03, 2022. The company gave VAPO a "Underweight" rating, the same as its previous rate.

Vapotherm Financial Forecast


Vapotherm Revenue Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jul 23Mar 23Dec 22Sep 22Jul 22
Revenue----$15.17M-$17.73M$18.66M$13.54M-
Avg Forecast$17.41M$16.88M$20.90M$19.92M$16.29M$24.96M$23.78M$19.91M$33.98M$22.69M
High Forecast$17.41M$16.88M$20.90M$20.10M$16.98M$29.95M$28.54M$23.89M$40.77M$27.23M
Low Forecast$17.41M$16.88M$20.90M$19.73M$15.60M$19.96M$19.03M$15.93M$27.18M$18.15M
# Analysts--1121613161419
Surprise %----0.93%-0.75%0.94%0.40%-

Vapotherm's average Quarter revenue forecast for Dec 23 based on 1 analysts is $19.92M, with a low forecast of $19.73M, and a high forecast of $20.10M. VAPO's average Quarter revenue forecast represents a 31.32% increase compared to the company's last Quarter revenue of $15.17M (Sep 23).

Vapotherm EBITDA Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jul 23Mar 23Dec 22Sep 22Jul 22
# Analysts--1121613161419
EBITDA----$-10.27M-$-13.62M$-15.93M$-19.13M-
Avg Forecast$-10.96M$-10.63M$-16.35M$-12.54M$-10.25M$-17.68M$-14.87M$-18.59M$-12.25M$-16.07M
High Forecast$-10.96M$-10.63M$-13.08M$-12.42M$-9.82M$-14.14M$-11.89M$-14.87M$-9.80M$-12.86M
Low Forecast$-10.96M$-10.63M$-19.62M$-12.65M$-10.69M$-21.22M$-17.84M$-22.31M$-14.70M$-19.29M
Surprise %----1.00%-0.92%0.86%1.56%-

undefined analysts predict VAPO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Vapotherm's previous annual EBITDA (undefined) of $NaN.

Vapotherm Net Income Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jul 23Mar 23Dec 22Sep 22Jul 22
# Analysts--1121613161419
Net Income----$-15.13M-$-18.09M$-21.44M$-26.20M-
Avg Forecast$9.93M$8.65M$-17.78M$-10.50M$-13.92M$-19.91M$-16.16M$-20.87M$-14.33M$-18.10M
High Forecast$9.93M$8.65M$-14.22M$-10.50M$-13.92M$-15.93M$-12.93M$-16.70M$-11.46M$-14.48M
Low Forecast$9.93M$8.65M$-21.34M$-10.50M$-14.43M$-23.90M$-19.40M$-25.04M$-17.19M$-21.72M
Surprise %----1.09%-1.12%1.03%1.83%-

Vapotherm's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. VAPO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Vapotherm SG&A Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jul 23Mar 23Dec 22Sep 22Jul 22
# Analysts--1121613161419
SG&A----$12.40M-$15.36M$16.52M$17.94M-
Avg Forecast$15.82M$15.34M$17.27M$18.10M$14.80M$24.72M$15.70M$18.09M$29.28M$22.47M
High Forecast$15.82M$15.34M$20.72M$18.26M$15.43M$29.66M$18.84M$21.71M$35.14M$26.96M
Low Forecast$15.82M$15.34M$13.81M$17.93M$14.17M$19.77M$12.56M$14.47M$23.42M$17.98M
Surprise %----0.84%-0.98%0.91%0.61%-

Vapotherm's average Quarter SG&A projection for Dec 23 is $18.10M, based on 1 Wall Street analysts, with a range of $17.93M to $18.26M. The forecast indicates a 45.98% rise compared to VAPO last annual SG&A of $12.40M (Sep 23).

Vapotherm EPS Forecast

Sep 24Jun 24Mar 24Dec 23Sep 23Jul 23Mar 23Dec 22Sep 22Jul 22
# Analysts--1121613161419
EPS----$-0.00-$-0.45$-0.78$-0.98-
Avg Forecast$1.54$1.34$-1.60$-1.63$-2.16$1.19$1.43$1.95$1.27$1.15
High Forecast$1.54$1.34$-1.60$-1.63$-2.16$1.19$1.43$1.95$1.27$1.15
Low Forecast$1.54$1.34$-1.60$-1.63$-2.24$1.19$1.43$1.95$1.27$1.15
Surprise %----0.00%--0.31%-0.40%-0.77%-

According to undefined Wall Street analysts, Vapotherm's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to VAPO previous annual EPS of $NaN (undefined).

Vapotherm Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
BJDXBluejay Diagnostics$0.15$10.006566.67%Buy
VAPOVapotherm$2.16$128.005825.93%Hold
RPIDRapid Micro Biosystems$0.84$8.00852.38%Hold
NPCENeuroPace$7.43$12.8873.35%Buy
SGHTSight Sciences$6.95$10.3348.63%Hold
HSCSHeart Test Laboratories$3.04$3.00-1.32%Buy

VAPO Forecast FAQ


No, according to 2 Wall Street analysts, Vapotherm (VAPO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of VAPO's total ratings.

Vapotherm (VAPO) average price target is $128 with a range of $128 to $128, implying a 5825.93% from its last price of $2.16. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for VAPO stock, the company can go up by 5825.93% (from the last price of $2.16 to the average price target of $128), up by 5825.93% based on the highest stock price target, and up by 5825.93% based on the lowest stock price target.

VAPO's average twelve months analyst stock price target of $128 supports the claim that Vapotherm can reach $3 in the near future.

VAPO's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $84.95M (high $95.57M, low $74.33M), average EBITDA is $-55.339M (high $-48.28M, low $-62.398M), average net income is $-60.496M (high $-53.28M, low $-68.227M), average SG&A $73.31M (high $82.19M, low $64.44M), and average EPS is $-1.169 (high $-1.169, low $-1.249).

Based on Vapotherm's last annual report (Dec 2022), the company's revenue was $66.8M, which missed the average analysts forecast of $76.58M by -12.77%. Apple's EBITDA was $-72.127M, beating the average prediction of $-46.915M by 53.74%. The company's net income was $-113M, beating the average estimation of $-53.299M by 112.50%. Apple's SG&A was $73.89M, beating the average forecast of $69.84M by 5.79%. Lastly, the company's EPS was $-4.24, missing the average prediction of $4.38 by -196.80%. In terms of the last quarterly report (Sep 2023), Vapotherm's revenue was $15.17M, missing the average analysts' forecast of $16.29M by -6.89%. The company's EBITDA was $-10.271M, beating the average prediction of $-10.255M by 0.16%. Vapotherm's net income was $-15.13M, beating the average estimation of $-13.916M by 8.72%. The company's SG&A was $12.4M, missing the average forecast of $14.8M by -16.25%. Lastly, the company's EPS was $-0.0024, missing the average prediction of $-2.16 by -99.89%